Etodolac and Fenofibrate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Etodolac (etodolac) and Fenofibrate (fenofibrate). Common drug interactions include kidney infection among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Etodolac and Fenofibrate. It is created by eHealthMe based on reports of 84 people who take the same drugs from the FDA, and is updated regularly.

What is Etodolac?

Etodolac has active ingredients of etodolac. It is often used in arthritis. eHealthMe is studying from 9,157 Etodolac users. Check the latest studies of Etodolac.

What is Fenofibrate?

Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,457 Fenofibrate users. Check the latest studies of Fenofibrate.

On Aug, 08, 2026

84 people who take Etodolac and Fenofibrate together, and have interactions are studied.

Etodolac and Fenofibrate drug interactions.

What are the common drug interactions of Etodolac and Fenofibrate, by gender? *:

female:

Kidney infection
Nephrogenic anaemia (anaemia due to kidney disease)
Cartilage atrophy (cartilage extra growth)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Headache (pain in head)
Muscle spasms (muscle contraction)
Oxygen saturation decreased
Pancreatic duct obstruction
Peripheral swelling
Photopsia (presence of perceived flashes of light)

male:

Chronic kidney disease
Anxiety
Somnolence (a state of near-sleep, a strong desire for sleep)
Gait disturbance
Depression
Drug ineffective
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Diarrhoea
Renal injury (kidney injury)
Stress fracture (fracture of a bone caused by repeated (rather than sudden) mechanical stress)

What are the common drug interactions of Etodolac and Fenofibrate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Bone density decreased
Emotional distress
Fracture
Osteoporosis (bones weak and more likely to break)
Gait disturbance
Chronic kidney disease
Renal failure (kidney dysfunction)
Blindness transient (sudden loss of vision)

40-49:

Renal failure (kidney dysfunction)
Chronic kidney disease
Insomnia (sleeplessness)
Cystitis interstitial (unknown cause characterized by bladder pain)
Drug ineffective
Anxiety
Dizziness
Emotional distress
Fatigue (feeling of tiredness)
Nephrogenic anaemia (anaemia due to kidney disease)

50-59:

Bipolar disorder (mood disorder)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cyst (a closed sac)
Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
Emotional distress
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Head banging (violently shaking the head in time with the music)
Head injury
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Injection site haemorrhage (bleeding from injection site)

60+:

Chronic kidney disease
Back pain
Gait disturbance
Incontinence (lack of moderation or self-control)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cartilage atrophy (cartilage extra growth)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Depression
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hypertension (high blood pressure)

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 27 people, 32.14%
High Blood Pressure: 23 people, 27.38%
Pain: 19 people, 22.62%
Stress And Anxiety: 17 people, 20.24%
Infection: 12 people, 14.29%
Diabetes: 12 people, 14.29%
Depression: 9 people, 10.71%
Insomnia (sleeplessness): 7 people, 8.33%
Neuralgia (pain in one or more nerves): 6 people, 7.14%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Etodolac and Fenofibrate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously